Welcome to our dedicated page for Balchem news (Ticker: BCPC), a resource for investors and traders seeking the latest updates and insights on Balchem stock.
Balchem Corporation (NASDAQ: BCPC) is a global specialty ingredient manufacturer for health and nutrition markets, and its news flow reflects this focus. Company press releases highlight the development, manufacture and marketing of specialty ingredients that improve and enhance the health and well-being of life on the planet, as well as financial and corporate updates relevant to investors and industry observers.
Visitors to this BCPC news page can review Balchem’s announcements on quarterly financial results, dividend declarations and participation in investor conferences. Recent releases have reported segment-level performance for its Human Nutrition & Health, Animal Nutrition & Health and Specialty Products segments, along with measures such as net sales, earnings from operations, adjusted EBITDA and free cash flow, as described in accompanying Form 8-K filings.
Balchem also issues news related to regulatory and trade developments that affect its markets. For example, the company joined another EU producer in welcoming European Union anti-dumping duties on choline chloride imports from China, emphasizing the importance of fair trade for the EU food and feed supply chain and for maintaining a healthy domestic choline chloride industry.
In addition, Balchem regularly announces its participation in conferences hosted by firms such as CJS Securities, Baird, H.C. Wainwright, Wells Fargo and others, where its leadership presents to the investment community. These updates provide insight into how the company communicates its strategy and segment performance to shareholders and analysts. Investors and researchers can use this news stream to follow Balchem’s financial reporting, capital allocation decisions such as dividends, and its commentary on market and regulatory conditions affecting its human nutrition, animal nutrition and specialty products businesses.
Balchem (NASDAQ: BCPC) announced that they will attend the Deutsche Bank Global Consumer Conference on June 4, 2024, in Montvale, NJ. The company specializes in manufacturing specialty ingredients for health and nutrition markets.
Representing Balchem at the conference will be Ted Harris, Chairman of the Board, President and CEO, and Martin Bengtsson, CFO. This event will provide an opportunity for the company to engage with investors and industry stakeholders.
Balchem (NASDAQ: BCPC) reported record net sales of $239.7 million, net earnings of $29.0 million, adjusted EBITDA of $60.9 million, and free cash flow of $26.8 million for the first quarter of 2024. The Human Nutrition & Health segment saw significant growth, with sales up 15.1% and earnings up 80.4% compared to the prior year. The Animal Nutrition & Health segment experienced a decrease in sales, while the Specialty Products segment remained stable. The company's strong financial performance and sustainability initiatives signal a positive outlook for 2024.
The New York Jets have announced a multi-year partnership with VitaCholine, a Balchem Human Nutrition and Health brand, marking VitaCholine's first sponsorship and the first sponsorship in the Nutritional Ingredient category of a major professional sports team. The agreement includes territorial rights in the United States and the United Kingdom, entitlement of the New York Jets official website, and presenting partner status for a Jets road game. VitaCholine will be featured prominently on the team's website and at MetLife Stadium, aiming to raise awareness about the essential nutrient choline and its health benefits. This collaboration highlights the growing demand for solutions supporting mental and physical performance in the post-pandemic era.
Balchem (BCPC) will attend the BMO 19th Annual Global Farm to Market Conference on May 16, 2024. The conference will be attended by top executives, including Chairman Ted Harris, CFO Martin Bengtsson, and Senior Director Investor Relations Allison Baurichter.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.